Article
Multi-omics Profiling and Experimental Validation Identify APLNR as a Prognostic Biomarker Involved in Epithelial-Mesenchymal Transition and Immune Modulation in Gastric Cancer
2026-06-08
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> : Gastric cancer (GC) is a leading cause of global cancer mortality, with limited treatment options for advanced disease, underscoring the urgent need for novel biomarkers and therapeutic targets. The Apelin Receptor (APLNR), a G protein-coupled receptor, has been implicated in tumor progression, yet its comprehensive role in GC remains poorly characterized....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ae115b85-f837-55af-b98c-e78731984e31
- DOI
- 10.21203/rs.3.rs-9632334/v1
